doi:10.1016/j.bbadis.2006.01.005
Copyright © 2006 Elsevier B.V. All rights reserved.
The lack of effect of glucosamine sulphate on aggrecan mRNA expression and 35S-sulphate incorporation in bovine primary chondrocytes
Cheng-Juan Qu, Hannu M. Karjalainen, Heikki J. Helminen and Mikko J. Lammi
, 
Department of Anatomy, Institute of Biomedicine, University of Kuopio, PO Box 1627, 70211 Kuopio, Finland
Received 9 September 2005;
revised 17 January 2006;
accepted 20 January 2006.
Available online 10 February 2006.
References and further reading may be available for this article. To view references and further reading you must
purchase this article.
Abstract
Glucosamine and glucosamine sulphate have been promoted as a disease-modifying agent to improve the clinical symptoms of osteoarthritis. The precise mechanism of the action of the suggested positive effect of glucosamine or glucosamine sulphate on cartilage proteoglycans is not known, since the level of glucosamine in plasma remains very low after oral administration of glucosamine sulphate. We examined whether exogenous hexosamines or their sulphated forms would increase steady-state levels of aggrecan and hyaluronan synthase (HAS) or glycosaminoglycan synthesis using Northern blot and 35S-sulphate incorporation analyses. Total RNA was extracted from bovine primary chondrocytes which were cultured either in 1 mM concentration of glucosamine, galactosamine, mannosamine, glucosamine 3-sulphate, glucosamine 6-sulphate or galactosamine 6-sulphate for 0, 4, 8 and 24 h, or in three different concentrations (control, 100 μM and 1 mM) of glucosamine sulphate salt or glucose for 24 or 72 h. Northern blot assay showed that neither hexosamines nor glucosamine sulphate salt stimulated aggrecan and HAS-2 mRNA expression. Glycosaminoglycan synthesis remained at a control level in the treated cultures, with the exception of mannosamine which inhibited 35S-sulphate incorporation in low-glucose DMEM treatment. In our culture conditions, hexosamines or their sulphated forms did not increase aggrecan expression or 35S-sulphate incorporation.
Keywords: Osteoarthritis; Glucosamine sulphate; Bovine; Proteoglycan
Fig. 1. Northern blot analysis of aggrecan, procollagen (α1) II, HAS-2 mRNA, GAPDH and 28 S ribosomal RNA. (A) Aggrecan, procollagen (α1) II and HAS-2 expression on bovine primary chondrocytes at the end of culture period. (B) Total RNA samples were collected at 0, 4, 8 and 24 h after addition of different forms of sulphated and non-sulphated hexosamines at 1 mM concentrations. Representative Northern blots are presented. Three donors were used for three separate experiments. Glucosamine: GlcN, galactosamine: GalN, mannosamine: ManN, glucosamine 3-sulphate: GlcN-3S, glucosamine 6-sulphate: GlcN-6S, galactosamine 6-sulphate: GalN-6S.
Fig. 2. Effects of glucosamine sulphate (GS) salt or glucose (Glc) on aggrecan mRNA expression levels. (A) Representative Northern blot from the cultures of bovine primary chondrocytes. Chondrocytes from 13 individual animals were treated for 24 h with 0, 100 μM and 1 mM of glucosamine sulphate salt or glucose. Total RNAs (20 μg) were separated on a 1.0% agarose/formaldehyde gel, and the probes for aggrecan, GAPDH, and 28 S ribosomal RNA were used for analysis. (B) The average of densitometric analysis of aggrecan mRNAs from 13 donors analyzed with Northern blot assay. The data are presented as a percent of control ± standard deviation, and the control is the untreated culture.
Fig. 3. Effects of glucosamine sulphate (GS) salt on HAS-2 mRNA expression levels. Chondrocytes were treated for 24 h with 0, 10, 50, 100, 500 μM and 1 mM of glucosamine sulphate salt. Total RNAs (20 μg) were separated on a 1.0% agarose/formaldehyde gel, and the probes for aggrecan, HAS-2, GAPDH, and 28 S were used for analysis. HAS-2 could be detected in three cell isolates out of thirteen. (A) HAS-2 mRNA level was elevated at 100 μM concentration of glucosamine sulphate in one donor. (B) The average of densitometric analysis of HAS-2 mRNAs from 3 donors analyzed with Northern blot assay.
Table 1.
Effects of sulphated and non-sulphated hexosamines on glycosaminoglycan synthesis in high (4.5 g/l) or low (1.0 g/l) glucose concentration evaluated by 35S-sulphate incorporation analysis

Chondrocytes were cultured in the presence of 1 mM glucosamine (GlcN), galactosamine (GalN), mannosamine (ManN) or glucosamine 3-sulphate (GlcN-3S) in high or low glucose concentration. The differences between control (untreated groups) and treated groups were evaluated with non-parametric K-independent (Kruskal–Wallis test) and post hoc test.
P < 0.05.
Table 2.
Glycosaminoglycan (GAG) synthesis measured in the culture medium by 35S-sulphate incorporation analysis

Bovine primary chondrocytes were cultured in 0, 100 μM and 1 mM of glucosamine sulphate (GS) salt or glucose (Glc) in DMEM with or without serum for 24 or 72 h. The differences between control (untreated groups) and treated groups were evaluated with non-parametric K-independent (Kruskal–Wallis test) and post hoc test (no significant changes were observed).